©ºªA°ª¤s¥ý¹w¨¾°ª¤s¯g¡I ±M®a´¦°ª¤s¯g¥ÎÃĤ£¥u«Â¦Ó¿û

2023-10-06 2059

°ª¤s¯g©öµo¥Í©ó®ü©Þ¶W¹L2500¤½¤Øªº°ª®ü©Þ¦a°Ï¡AÃÄ®vªL«ä¶²«Øij¡A¥Á²³­Y±ý¬D¾ÔÃkµn°ª¤s¡AÀ³ª`·N¥ÎÃÄ3­ì«h»P±`¨£°ª¤s¯gÃÄ«~ª`·N¨Æ¶µ¡C

¬Ì±¡¸Ñ«Ê«á¡A·U¨Ó·U¦hµn¤s«È¬D¾Ô¥xÆW¦Ê©¨©Î·f¾÷ª¦°ê¥~¦W¤s¡A¤£¹L¡A­¹Ãĸp´£¿ô¡A°È¥²ª`·N°ª¤s¯g¹ï©ó¥Í©Rªº«Â¯Ù¡Aª¦¤s¹Lµ{¤¤¡A¦pªGÀYµh¡BÀY·w¡Bµê®z©Mäú¤ß¡A´N¤£­n³x±j¡A¿n·¥´M¨D¨ó§U¡C¤@¥¹¥X²{¸£¤ô¸~¡BªÍ¤ô¸~¡A´N¦³­P©R­·ÀI¡A¦]¦¹¡A¥Á²³¦bµn¤s«eÀ³´£«e³Æ¦nÃĪ«¡A¥H¹w¨¾°ª¤s¯g¡C

©ºªA°ª¤s«e¤£¥i¤£ª¾¡I ÃÄ®v¸ÑªR°ª¤s¯g¥ÎÃÄ3­ì«h

¥_¥«Áp¦XÂå°|¶§©ú°|°ÏÃÄ®vªL«ä¶²´£¥Xµn¤s«e¥²ª¾ªº¥ÎÃÄ3­ì«h¡A¥]¬A¡u¥Xµo«e¥ý¿Ô¸ß®È¹CÂå¾Çªù¶E¡v¡B¡uª`·N¨Ï¥Î¹w¨¾¥ÎÃĮɾ÷¡v¡B¡u¥D°Ê§i¶DÂå®v¯f¥v¡B¦w¥þ¥ÎÃÄ¡v¡A«Øij¥Á²³¦bµn¤s¤§«e¡AÀ³´x´¤³o3¤j­ì«h¡A¥H¨¾¤î°ª¤s¯gµo¥Í¡G

▸­ì«h1¡G¥Xµo«e¥ý¿Ô¸ß®È¹CÂå¾Çªù¶E

³y¦¨°ª¤s¯gªº¦MÀI¦]¤l¥]¬A®ü©Þ°ª«×¡BÃkª¦³t«×¡B­Ó¤HÅé½èµ¥¡A»P¥­®ÉªºÅé¤O©M¹B°Ê²ßºDµL¥²µMÃö«Y¡F¹ï©ó´¿¦³°ª¤s¯g¯f¥v©Î»Ý­n¦bµu®É¶¡¤º§Ö³tÃk¤É®ü©ÞªÌ¡A«Øij¥Xµo«e¥ý¿Ô¸ß®È¹CÂå¾Çªù¶E¡A¥ÑÂå®vµû¦ô¬O§_»Ý­nªA¥Î¹w¨¾°ª¤s¯gªºÃÄ«~¡C

▸­ì«h2¡Gª`·N¨Ï¥Î¹w¨¾¥ÎÃĮɾ÷

ªL«ä¶²«ü¥X¡A±`¨£¹w¨¾°ª¤s¯gÃÄ«~¥]¬Aacetazolamide¡Bnifedipine¡Btadalafil¡Bsildenafil©Mdexamethasoneµ¥¡A¨ä¤¤acetazolamide¯àÀ°§U¨­Åé§ó§Ö¦a¾AÀ³°ª®ü©ÞÀô¹Ò¡A¬O¹w¨¾«æ©Ê°ª¤s¯gªº­º¿ï¡C«Øij¦bÃkª¦«e1¤Ñ©Î·í¤Ñ¨Ï¥Î1¤Ñ2¦¸ªºacetazolamide125²@§J¡Aª½¨ì¤£¦A¤W¤É®ü©Þªº²Ä2©Î²Ä3¤Ñ¡A©Î¶}©l¤U­°®ü©Þ«á¤~°±¥Î¡C

▸­ì«h3¡G¥D°Ê§i¶DÂå®v¯f¥v¡B¦w¥þ¥ÎÃÄ

¹ï©óÁDÓiÃþÃÄ«~¹L±Ó¡B±w¦³Åú¨§¯g©ÎÃh¥¥ªº±wªÌ¡A¤£«Øij¨Ï¥Îacetazolamide¡CÃþ©T¾J¦pdexamethasone¥i°µ¬°´À¥NÃÄ«~¡A«Øij¦bª¦¤É·í¤Ñ¶}©lªA¥Î¡AªA¥Î¤è¦¡¬°¨C6¤p®Édexamethasone 2mg©Î¨C12¤p®Édexamethasone 4mg¡Aª½¨ì¤£¦A¤W¤Éªº²Ä2©Î²Ä3¤Ñ¡A©Î¬O¶}©l¤U­°®ü©Þ«á¤~°±¤î¨Ï¥Î¡F¤Á¤Å¦b«ùÄò¤W¤É¤¤¥ô·N°±ÃÄ¡AÁקK°±ÃÄ«á¯gª¬¤Ï¼uµo§@¡C¦b¿Ô¸ß®È¹Cªù¶E®É¡A°O±o¥D°Ê§iª¾Âå®v¬ÛÃö¯f¥v©M¹L±Ó±¡ªp¡C

¦¹¥~¡A§{¶¡¬y¶Ç¡u¹w¨¾°ª¤s¯g­n¦Y«Â¦Ó¿û¡vªº»¡ªk¡A¨Æ¹ê¤W¡A«Â¦Ó¿û¡]sildenafil¡^¥u¯à¹w¨¾µo¥Í¾÷²v¤£¨ì1%ªº°ª¤sªÍ¤ô¸~¡A¥B¿ù»~¨Ï¥Î¥i¯à·|¥[¼@«æ©Ê°ª¤s¯gªºÀYµh¯gª¬¡C

©è¹F°ª¦a«á´NÀYµh¡B·Q¦R¡H ¤½¶}°ª¤s¯g3¤jºØÃþ

°ª¤s¯g©öµo¥Í©ó®ü©Þ¶W¹L2500¤½¤Øªº°ª®ü©Þ¦a°Ï¡A¥i¤À¬°«æ©Ê°ª¤s¯g¡B°ª¤s¸£¤ô¸~©M°ª¤sªÍ¤ô¸~3Ãþ¡A¤À­z¦p¤U¡G

▸1.«æ©Ê°ª¤s¯g¡G ³Ì±`¨£ªº°ª¤s¯g¡A³q±`¦b©è¹F°ª¦a«áªº6¦Ü12¤p®É¤º¥X²{ÀYµh¡BÀY·w¡B¥¢¯v¡Bäú¤ß¡B¹Ã¦R¡B¹½­¹¡Bµê®zµ¥«D¯S²§©Ê¯gª¬¡C¯gª¬·|¦b2¦Ü3¤Ñ«áÀHµÛ¨­Åé¾AÀ³Àô¹Ò¦Ó½w¸Ñ¡A­È±oª`·Nªº¬O¡A¹Ã¦R¬O¯gª¬´c¤Æªº­«­n«ü¼Ð¡A¥²¶·¦h¥[¯d·N¡C

▸2.°ª¤s¸£¤ô¸~¡G ¤Ö¼Æµo¥Í«æ©Ê°ª¤s¯gªº®È«È´c¤Æ¬°°ª¤s¸£¤ô¸~¡A¯gª¬¬°ÄY­«ÀYµh¡B¶ÝºÎ¡B·NÃѤ£²M¡B¹B°Ê¥¢½Õ¡]¨BºA¤£Ã­¡^¡A¬Æ¦Ü©ü°g¡C¨BºA¤£Ã­¬O°ª¤s¸£¤ô¸~ªº­«­n«ü¼Ð¡A­Y¨S¦³§´µ½ªvÀø©Î­°§C°ª«×¡A24¤p®É¤º¥i¯à­P¦º¡C

▸3.°ª¤sªÍ¤ô¸~¡G ¯Ê®ñ®É·|³y¦¨ªÍ°Ê¯ßÀ£¤W¤É¡AªÍ³¡¦åºÞ³q³z©Ê¼W¥[¡A¨Ï¦å²G¤¤¤ô¥÷¥~º¯¨ìªÍ³¡¡A¯gª¬¬°¹B°Ê¯à¤OÅÜ®t¡B¥ð®§ª¬ºA¤U¤´¤£°±³Ý®ð¡B°®«y¡B¯Ý´e¡AÀHµÛ¯e¯f´c¤Æ¡A©I§l§xÃø¡B«y¹Â±a¦å¡BµoÖæ¡C

°ª¤sªÍ¤ô¸~­P¦º²v¤ñ¥t¥~2ºØ°ª¤s¯g§ó°ª¡A¦pªG³Ý®ð©M©I§l§xÃø¡A¦b¥ð®§«á¤´¥¼¯à½w¸Ñ¡A´N­n¦Ò¼{¬O§_¥X²{°ª¤sªÍ¤ô¸~¡Aµ¹¤©®ñ®ð¡A¨Ã¥ß¨è¤U¤s¡A­°§C®ü©Þ°ª«×¡C¡]³s¼z´@¡þ¥x¥_³ø¾É¡^

¡]®Ö½Z½s¿è¡G³¯¬Ã©g¡^
¡]¹Ï¡þNOW°·±d»s§@¡F¹Ï¤ù¨Ó·½¡þingimage¡^
¨Ó·½¡G©ºªA°ª¤s¥ý¹w¨¾°ª¤s¯g¡I ±M®a´¦°ª¤s¯g¥ÎÃĤ£¥u«Â¦Ó¿û
¥X³B¡GNOW°·±d

ment,'script','//www.google-analytics.com/analytics.js','ga'); ga('create', 'UA-35937129-1', 'auto'); ga('send', 'pageview');